Position in CDXS
as of Mar 31, 2026
· filed May 5, 2026
Position Value
$3,559,552
+$2,240,036 QoQ
Shares Held
2,183,775
+169.8% QoQ
Ownership
2.40%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Mar 2020
25 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in CDXS Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Mar 31, 2026UBS Group AG holds $7,582,894,358 across 563 Biotechnology names. CDXS ranks #161 (0.0% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | ROIV |
Roivant Sciences Ltd.
|
22,619,472 | $626,559,372 | |
| 2 | PTGX |
Protagonist Therapeutics, Inc
|
5,177,796 | $545,739,697 | |
| 3 | ABVX |
Abivax S.A.
|
4,547,406 | $506,353,656 | |
| 4 | RVMD |
Revolution Medicines, Inc.
|
4,386,791 | $426,615,424 | |
| 5 | INSM |
INSMED Inc
|
1,737,481 | $284,112,890 | |
| 6 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
630,618 | $281,596,158 | |
| 7 | REGN |
Regeneron Pharmaceuticals, Inc.
|
299,979 | $231,775,770 | |
| 8 | MRNA |
Moderna, Inc.
|
4,407,907 | $223,921,674 |
All Filings in CDXS
Export CSV
25 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $3,559,552 | 2,183,775 | Shares | Defined | 2026-05-05 | |
| 2025-12-31 | $1,319,516 | 809,520 | Shares | Defined | 2026-01-29 | |
| 2025-09-30 | $1,274,613 | 522,383 | Shares | Defined | 2025-11-13 | |
| 2025-06-30 | $424,927 | 174,151 | Shares | Defined | 2025-08-14 | |
| 2025-03-31 | $785,438 | 291,985 | Shares | Defined | 2025-05-13 | |
| 2024-12-31 | $253,696 | 53,186 | Shares | Defined | 2025-02-14 | |
| 2024-09-30 | $118,093 | 38,342 | Shares | Defined | 2024-11-14 | |
| 2024-06-30 | $66,876 | 21,573 | Shares | Defined | 2024-08-14 | |
| 2024-03-31 | $255,921 | 73,330 | Shares | Defined | 2024-05-13 | |
| 2023-12-31 | $213,334 | 69,946 | Shares | Defined | 2024-02-09 | |
| 2023-09-30 | $30,859 | 16,328 | Shares | Defined | 2023-11-09 | |
| 2023-06-30 | $156,357 | 55,842 | Shares | Defined | 2023-08-11 | |
| 2023-03-31 | $155,125 | 37,470 | Shares | Defined | 2023-05-12 | |
| 2022-12-31 | $236,438 | 50,738 | Shares | Defined | 2023-02-08 | |
| 2022-09-30 | $76,659 | 12,650 | Shares | Defined | 2022-11-10 | |
| 2022-06-30 | $10,104 | 966 | Shares | Defined | 2022-08-10 | |
| 2022-03-31 | $21,279 | 1,032 | Shares | Defined | 2022-05-16 | |
| 2021-12-31 | $70,012 | 2,239 | Shares | Defined | 2022-02-14 | |
| 2021-09-30 | $24,911 | 1,071 | Shares | Defined | 2021-11-15 | |
| 2021-06-30 | $77,745 | 3,431 | Shares | Defined | 2021-08-13 | |
| 2021-03-31 | $319,796 | 13,971 | Shares | Defined | 2021-05-12 | |
| 2020-12-31 | $165,056 | 7,561 | Shares | Defined | 2021-02-11 | |
| 2020-09-30 | $130,278 | 11,097 | Shares | Defined | 2020-11-12 | |
| 2020-06-30 | $312,918 | 27,449 | Shares | Defined | 2020-07-31 | |
| 2020-03-31 | $399,494 | 35,797 | Shares | Defined | 2020-05-01 | |
| No filing history on record for this holder in this stock. | ||||||